This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Management of severe heart failure

Authoring team

Patients with severe chronic heart failure may be receiving a treatment regime including diuretics, ACE inhibitors, beta-blockers and spironolactone.

NICE have recommended ivabradine as an additional possible treatment

  • in combination with standard therapy including betablocker therapy, angiotensin-converting enzyme (ACE) inhibitors and aldosterone antagonists, or when beta-blocker therapy is contraindicated or not tolerated (1)

Patients with extremely resistant oedema may also be given additional therapies. These may include:

  • loop diuretic potentiated with a thiazide diuretic such as metolazone
  • nitrate vasodilator
  • digoxin

Heart transplantation is a treatment of last resort in selected patients with severe heart failure.

Reference:

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.